发明名称 Verwendung von Papillomavirusprotein L2 zur therapeutischen Behandlung von durch Papillomavirus hervorgerufenen Tumoren oder oder anderen krankhaften Veränderungen
摘要 <p>The L2 protein of papillomavirus (particularly BPV-2 and BPV-4) has been cloned as a fusion protein with beta-galactosi-dase and GST; both as the whole protein and as fragments. Vaccination of calves is found to have both a prophylactic effect in tumor prevention and a therapeutic effect in tumor regression.</p>
申请公布号 DE69229050(T2) 申请公布日期 1999.10.21
申请号 DE1992629050T 申请日期 1992.06.17
申请人 CANCER RESEARCH CAMPAIGN TECHNOLOGY LTD., LONDON 发明人 JARRETT, WILLIAM FLEMING HOGGAN;CAMPO, MARIA;SMITH, KENNETH
分类号 A61K38/00;A61K39/12;A61K39/39;A61P31/12;A61P31/20;A61P35/00;C07K14/00;C07K14/025;C07K19/00;C12N1/21;C12N15/09;C12N15/37;C12R1/19;(IPC1-7):C12N15/37 主分类号 A61K38/00
代理机构 代理人
主权项
地址